Significance of the Expression of TC and TG Levels in the Initial Diagnosis and Treatment of SCLC Patients and Their Tie-In with Prognosis

• Published in: Contrast media and molecular imaging Vol. 2022; no. 1; p. 1297072
• Main Authors: Chen, Qiankun, Tang, Feng, Zhang, Haiping
• Format: Journal Article
• Language: English
• Published: Hindawi 2022
• ISSN: 1555-4309; 1555-4317; 1555-4317
• DOI: 10.1155/2022/1297072

The article examines the expression of TC and TG levels in the initial diagnosis and treatment of SCLC patients and their tie-in with prognosis. Patients with SCLC are included in the case set, who are initially treated in the tumor center of our hospital from January 2020 to January 2021 and are confirmed by histopathology or cytology as the research subjects. 80 healthy volunteers are included in the control set, who received physical examination. All the enrolled patients received the first-line standard treatment plan, and the clinical data of all SCLC patients are inquired through the medical record file system of the hospital. At the initial diagnosis and treatment, the TG and TC levels of all patients and healthy persons are measured and recorded by blood biochemistry. For SCLC patients, the risk factors affecting the prognosis of patients with progression-free survival include newly diagnosed TC, TG levels, and tumor stage. Combined TC and TG detection can be used as indicators to predict the prognosis of the patients. TC and TG are significantly correlated with the prognosis of the patients with progression-free survival time. It is worthy of clinical application.